These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 26052950)

  • 1. Designing and Testing of Novel Taxanes to Probe the Highly Complex Mechanisms by Which Taxanes Bind to Microtubules and Cause Cytotoxicity to Cancer Cells.
    St George M; Ayoub AT; Banerjee A; Churchill CD; Winter P; Klobukowski M; Cass CE; Ludueña RF; Tuszynski JA; Damaraju S
    PLoS One; 2015; 10(6):e0129168. PubMed ID: 26052950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple mechanisms underlying acquired resistance to taxanes in selected docetaxel-resistant MCF-7 breast cancer cells.
    Wang H; Vo T; Hajar A; Li S; Chen X; Parissenti AM; Brindley DN; Wang Z
    BMC Cancer; 2014 Jan; 14():37. PubMed ID: 24447372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding modes of cabazitaxel with the different human β-tubulin isotypes: DFT and MD studies.
    Zhu L; Zhang C; Lü X; Song C; Wang C; Zhang M; Xie Y; Schaefer HF
    J Mol Model; 2020 May; 26(6):162. PubMed ID: 32474655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Taxanes with high potency inducing tubulin assembly overcome tumoural cell resistances.
    Matesanz R; Trigili C; Rodríguez-Salarichs J; Zanardi I; Pera B; Nogales A; Fang WS; Jímenez-Barbero J; Canales A; Barasoain I; Ojima I; Díaz JF
    Bioorg Med Chem; 2014 Sep; 22(18):5078-90. PubMed ID: 25047938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elucidating the mechanism of action of the clinically approved taxanes: a comprehensive comparison of local and allosteric effects.
    Churchill CD; Klobukowski M; Tuszynski JA
    Chem Biol Drug Des; 2015 Nov; 86(5):1253-66. PubMed ID: 26032329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Taxol Analogues Exhibit Differential Effects on Photoaffinity Labeling of β-Tubulin and the Multidrug Resistance Associated P-Glycoprotein.
    Yang CH; Wang C; Ojima I; Horwitz SB
    J Nat Prod; 2018 Mar; 81(3):600-606. PubMed ID: 29517223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel mutations involving βI-, βIIA-, or βIVB-tubulin isotypes with functional resemblance to βIII-tubulin in breast cancer.
    Wang W; Zhang H; Wang X; Patterson J; Winter P; Graham K; Ghosh S; Lee JC; Katsetos CD; Mackey JR; Tuszynski JA; Wong GK; Ludueña RF
    Protoplasma; 2017 May; 254(3):1163-1173. PubMed ID: 27943021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MAC-321, a novel taxane with greater efficacy than paclitaxel and docetaxel in vitro and in vivo.
    Sampath D; Discafani CM; Loganzo F; Beyer C; Liu H; Tan X; Musto S; Annable T; Gallagher P; Rios C; Greenberger LM
    Mol Cancer Ther; 2003 Sep; 2(9):873-84. PubMed ID: 14555706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. βIII-tubulin enhances efficacy of cabazitaxel as compared with docetaxel.
    Smiyun G; Azarenko O; Miller H; Rifkind A; LaPointe NE; Wilson L; Jordan MA
    Cancer Chemother Pharmacol; 2017 Jul; 80(1):151-164. PubMed ID: 28567478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural insight into the stabilization of microtubules by taxanes.
    Prota AE; Lucena-Agell D; Ma Y; Estevez-Gallego J; Li S; Bargsten K; Josa-Prado F; Altmann KH; Gaillard N; Kamimura S; Mühlethaler T; Gago F; Oliva MA; Steinmetz MO; Fang WS; Díaz JF
    Elife; 2023 Mar; 12():. PubMed ID: 36876916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of an intermediate taxol binding site within microtubule nanopores and a mechanism for tubulin isotype binding selectivity.
    Freedman H; Huzil JT; Luchko T; Ludueña RF; Tuszynski JA
    J Chem Inf Model; 2009 Feb; 49(2):424-36. PubMed ID: 19434843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of taxane binding to tubulin curved and straight conformations by systematic 3'N modification provides for improved microtubule binding, persistent cytotoxicity and in vivo potency.
    Ma Y; Josa-Prado F; Essif JN; Liu S; Li S; Lucena-Agell D; Chan PY; Goossens K; Hortigüela R; Matesanz R; Wang Y; Gago F; Wang H; Risinger A; Diaz JF; Fang WS
    Eur J Med Chem; 2023 Nov; 259():115668. PubMed ID: 37490800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paclitaxel-resistant cells have a mutation in the paclitaxel-binding region of beta-tubulin (Asp26Glu) and less stable microtubules.
    Hari M; Loganzo F; Annable T; Tan X; Musto S; Morilla DB; Nettles JH; Snyder JP; Greenberger LM
    Mol Cancer Ther; 2006 Feb; 5(2):270-8. PubMed ID: 16505100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A semisynthetic taxane Yg-3-46a effectively evades P-glycoprotein and β-III tubulin mediated tumor drug resistance in vitro.
    Cai P; Lu P; Sharom FJ; Fang WS
    Cancer Lett; 2013 Dec; 341(2):214-23. PubMed ID: 23941826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Markers predicting clinical benefit in breast cancer from microtubule-targeting agents.
    Pusztai L
    Ann Oncol; 2007 Dec; 18 Suppl 12():xii15-20. PubMed ID: 18083698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into the interaction of discodermolide and docetaxel with tubulin. Mapping the binding sites of microtubule-stabilizing agents by using an integrated NMR and computational approach.
    Canales A; Rodríguez-Salarichs J; Trigili C; Nieto L; Coderch C; Andreu JM; Paterson I; Jiménez-Barbero J; Díaz JF
    ACS Chem Biol; 2011 Aug; 6(8):789-99. PubMed ID: 21539341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probing the pore drug binding site of microtubules with fluorescent taxanes: evidence of two binding poses.
    Barasoain I; García-Carril AM; Matesanz R; Maccari G; Trigili C; Mori M; Shi JZ; Fang WS; Andreu JM; Botta M; Díaz JF
    Chem Biol; 2010 Mar; 17(3):243-53. PubMed ID: 20338516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical pharmacologic evaluation of MST-997, an orally active taxane with superior in vitro and in vivo efficacy in paclitaxel- and docetaxel-resistant tumor models.
    Sampath D; Greenberger LM; Beyer C; Hari M; Liu H; Baxter M; Yang S; Rios C; Discafani C
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3459-69. PubMed ID: 16740771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of novel taxanes SB-T-1213 and IDN5109 on tubulin polymerization and mitosis.
    Jordan MA; Ojima I; Rosas F; Distefano M; Wilson L; Scambia G; Ferlini C
    Chem Biol; 2002 Jan; 9(1):93-101. PubMed ID: 11841942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paclitaxel and docetaxel resistance: molecular mechanisms and development of new generation taxanes.
    Galletti E; Magnani M; Renzulli ML; Botta M
    ChemMedChem; 2007 Jul; 2(7):920-42. PubMed ID: 17530726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.